Keywords: Ipsen, Full-year 2011 financial results
Strong international drug sales drive Ipsen 2011
Article | 03 February 2012
French drugmaker Ipsen (Euronext: IPN) reported that, in full-year 2011, group drug sales grew by 5.7% year-on-year excluding foreign exchange impacts. Consolidated ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
